This group also showed conserved expression dynamics and function in mouse HE, in part by observing reduced hematopoietic output from explanted AGMs treated with a chemical inhibitor of the endogenous Gpr183 ligand. The gene discussed is GPR183; the disease is hereditary elliptocytosis.